Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer-Reference-Cited by-同舟云学术

Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer

Published:2017-08-16 Issue:1 Volume:121 Page:69-76
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Basourakos Spyridon P.¹,Davis John W.²^ORCID,Chapin Brian F.²,Ward John F.²,Pettaway Curtis A.²,Pisters Louis L.²,Navai Neema²,Achim Mary F.²,Wang Xuemei³,Chen Hsiang-Chun³,Choi Seungtaek⁴,Kuban Deborah⁴,Troncoso Patricia⁵,Hanash Sam⁶,Thompson Timothy C.¹,Kim Jeri¹

Affiliation:

1. Department of Genitourinary Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Urology; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

4. Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

5. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

6. Department of Clinical Cancer Prevention; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13963/fullpdf

Reference30 articles.

1. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA,2015

2. Active surveillance for prostate cancer: a narrative review of clinical guidelines;Bruinsma;Nat Rev Urol,2016

3. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

4. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci;Davis;BJU Int,2010

5. Active surveillance for prostate cancer: current evidence and contemporary state of practice;Tosoian;Nat Rev Urol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer;Discover Oncology;2023-11-01

2. Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria;Urologia Internationalis;2022

3. Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review;Cancers;2021-08-24

4. Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer;Nature Communications;2020-08-27

5. Caveola-forming proteins and prostate cancer;Cancer and Metastasis Reviews;2020-05-01